Maryam I. Daneshvar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maryam I. Daneshvar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Robbin S. Weyant
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases,1 Division of Healthcare Quality Promotion, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia2
4 shared publicationsAnne M. Whitney
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases,1 Division of Healthcare Quality Promotion, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia2
3 shared publicationsArnold G. Steigerwalt
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases,1 Division of Healthcare Quality Promotion, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia2
3 shared publicationsDannie G. Hollis
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases,1 Division of Healthcare Quality Promotion, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia2
3 shared publicationsJean G. Jordan
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases,1 Division of Healthcare Quality Promotion, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia2
3 shared publications- Michael P. Douglas
San Francisco Veterans Affairs Health Care System, San Francisco, USA
3 shared publications
Latest Publications
- Open Access
- 1 September 2004
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (9) , 4189-4198
Identification of Some Charcoal-Black-Pigmented CDC Fermentative Coryneform Group 4 Isolates asRothia dentocariosaand Some asCorynebacterium aurimucosum: Proposal ofRothia dentocariosaemend. Georg and Brown 1967,Corynebacterium aurimucosumemend. Yassin et al. 2002, andCorynebacterium nigricansShukla et al. 2003 pro synon.Corynebacterium aurimucosum
Sixty-three clinical isolates of charcoal-black-pigmented, gram-positive coryneform rods were received for identification by the Centers for Disease Control and Prevention (CDC) and were provisionally designated CDC fermentative coryneform group 4 (FCG4). Forty-five of these were characterized by morphological, physiologic, antimicrobial susceptibility, cellular fatty acids, 16S rRNA gene sequencing, and DNA-DNA hybridization analyses. Nitrate reduction, cellular fatty acid analysis, 16S rRNA gene sequencing, and DNA-DNA hybridization studies segregated these strains into two groups: FCG4a (8 strains) and FCG4b (37 strains). The FCG4a strains, only one of which was from a female genitourinary source, produced cellular fatty acid and biochemical profiles similar to those observed with reference strains ofRothia dentocariosaandRothia mucilaginosa, while the FCG4b strains were similar toCorynebacteriumspecies. DNA-DNA hybridization analysis demonstrated species-level relatedness among six FCG4a tested strains and showed that they were a charcoal-black-pigmented variant ofR. dentocariosa. Sixteen isolates of the FCG4b group, mainly from female genitourinary tract specimens, as well as the type strains of two recently named species,Corynebacterium aurimucosumandCorynebacterium nigricans, were shown by DNA-DNA hybridization analysis and the sequencing of the 16S rRNA gene to be related at the species level and unrelated to the type strain ofR. dentocariosa; therefore, theCorynebacterium-like strains were classified as a charcoal-black-pigmented variant ofC. aurimucosum, because this name has nomenclatural priority overC. nigricans. These findings indicate that FCG4 represents a heterogeneous group that contains pigmented variants of bothR. dentocariosaandC. aurimucosum; hence, the descriptions of bothR. dentocariosaandC. aurimucosumhave been amended to include charcoal-black-pigmented variants, andC. nigricansis a pro synonym ofC. aurimucosum.
- 1 September 2004
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (9) , 4189-4198
Open AccessIdentification of Some Charcoal-Black-Pigmented CDC Fermentative Coryneform Group 4 Isolates asRothia dentocariosaand Some asCorynebacterium aurimucosum: Proposal ofRothia dentocariosaemend. Georg and Brown 1967,Corynebacterium aurimucosumemend. Yassin et al. 2002, andCorynebacterium nigricansShukla et al. 2003 pro synon.Corynebacterium aurimucosum
Sixty-three clinical isolates of charcoal-black-pigmented, gram-positive coryneform rods were received for identification by the Centers for Disease Control and Prevention (CDC) and were provisionally designated CDC fermentative coryneform group 4 (FCG4). Forty-five of these were characterized by morphological, physiologic, antimicrobial susceptibility, cellular fatty acids, 16S rRNA gene sequencing, and DNA-DNA hybridization analyses. Nitrate reduction, cellular fatty acid analysis, 16S rRNA gene sequencing, and DNA-DNA hybridization studies segregated these strains into two groups: FCG4a (8 strains) and FCG4b (37 strains). The FCG4a strains, only one of which was from a female genitourinary source, produced cellular fatty acid and biochemical profiles similar to those observed with reference strains ofRothia dentocariosaandRothia mucilaginosa, while the FCG4b strains were similar toCorynebacteriumspecies. DNA-DNA hybridization analysis demonstrated species-level relatedness among six FCG4a tested strains and showed that they were a charcoal-black-pigmented variant ofR. dentocariosa. Sixteen isolates of the FCG4b group, mainly from female genitourinary tract specimens, as well as the type strains of two recently named species,Corynebacterium aurimucosumandCorynebacterium nigricans, were shown by DNA-DNA hybridization analysis and the sequencing of the 16S rRNA gene to be related at the species level and unrelated to the type strain ofR. dentocariosa; therefore, theCorynebacterium-like strains were classified as a charcoal-black-pigmented variant ofC. aurimucosum, because this name has nomenclatural priority overC. nigricans. These findings indicate that FCG4 represents a heterogeneous group that contains pigmented variants of bothR. dentocariosaandC. aurimucosum; hence, the descriptions of bothR. dentocariosaandC. aurimucosumhave been amended to include charcoal-black-pigmented variants, andC. nigricansis a pro synonym ofC. aurimucosum.
- Open Access
- 1 March 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (3) , 1289-1294
Paracoccus yeeii sp. nov. (Formerly CDC Group EO-2), a Novel Bacterial Species Associated with Human Infection
CDC eugonic oxidizer group 2 (EO-2) is a group of unclassified gram-negative bacterial strains isolated from various human sources. As determined by biochemical tests and analyses of fatty acid compositions, these organisms form a homogeneous group that appears to be distinct from but related to other Paracoccus species. Molecular studies were performed on a set of 13 EO-2 strains from various clinical sources and geographic locations in the United States and Canada to determine their relationship to the Paracoccus genus. Control strains were Paracoccus denitrificans ATCC 17741 T , P. versutus ATCC 25364 T , P. aminophilus ATCC 49673 T , P. solventivorans ATCC 700252 T , and Psychrobacter immobilis ATCC 43116 T , which are phenotypically similar to EO-2. Nearly complete (1,500-base) 16S rRNA gene sequencing of eight EO-2 strains showed a high level of sequence similarity (>99.3%) within the group, and a BLAST search of GenBank placed the EO-2 cluster in close proximity to Paracoccus species (95 to 97% similarity). DNA-DNA hybridization studies of 13 of the EO-2 strains showed all to be related at the species level, with >70% relatedness under stringent conditions and a divergence within the group of less than 2%. None of the Paracoccus control strains hybridized at >54% with any of the EO-2 strains. These results indicate that EO-2 represents a new Paracoccus species, the first isolated from human clinical specimens. A new species, Paracoccus yeeii , is proposed for the EO-2 strains. The type strain of P. yeeii is CDCG1212 (ATCC BAA-599 and CCUG 46822), isolated in Pennsylvania from dialysate of a 77-year-old male with peritonitis.
- 1 March 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (3) , 1289-1294
Open AccessParacoccus yeeii sp. nov. (Formerly CDC Group EO-2), a Novel Bacterial Species Associated with Human Infection
CDC eugonic oxidizer group 2 (EO-2) is a group of unclassified gram-negative bacterial strains isolated from various human sources. As determined by biochemical tests and analyses of fatty acid compositions, these organisms form a homogeneous group that appears to be distinct from but related to other Paracoccus species. Molecular studies were performed on a set of 13 EO-2 strains from various clinical sources and geographic locations in the United States and Canada to determine their relationship to the Paracoccus genus. Control strains were Paracoccus denitrificans ATCC 17741 T , P. versutus ATCC 25364 T , P. aminophilus ATCC 49673 T , P. solventivorans ATCC 700252 T , and Psychrobacter immobilis ATCC 43116 T , which are phenotypically similar to EO-2. Nearly complete (1,500-base) 16S rRNA gene sequencing of eight EO-2 strains showed a high level of sequence similarity (>99.3%) within the group, and a BLAST search of GenBank placed the EO-2 cluster in close proximity to Paracoccus species (95 to 97% similarity). DNA-DNA hybridization studies of 13 of the EO-2 strains showed all to be related at the species level, with >70% relatedness under stringent conditions and a divergence within the group of less than 2%. None of the Paracoccus control strains hybridized at >54% with any of the EO-2 strains. These results indicate that EO-2 represents a new Paracoccus species, the first isolated from human clinical specimens. A new species, Paracoccus yeeii , is proposed for the EO-2 strains. The type strain of P. yeeii is CDCG1212 (ATCC BAA-599 and CCUG 46822), isolated in Pennsylvania from dialysate of a 77-year-old male with peritonitis.
- Open Access
- 1 November 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (11) , 4160-4162
Cellular Fatty Acid Composition of Lautropia mirabilis
Ten strains of Lautropia mirabilis (ATCC 51599 T and nine phenotypically similar clinical isolates) were examined for cellular fatty acid (CFA) composition to evaluate their chemical relatedness to known bacterial species and groups. The CFAs were liberated from whole cells by base hydrolysis, methylated, and analyzed by gas-liquid chromatography. CFA profiles were generated by using a commerical software package (MIDI, Newark, Del.). All strains tested had an identical CFA profile characterized by major amounts of 16:1ω7c (41%) and 16:0 (44%); smaller amounts (1 to 4%) of 3-OH-10:0, 12:0, 14:0, 15:0, and 18:1 ω7c; trace amounts (Acidovorax delafieldii, Comamonas terrigena , and strains of an unclassified Centers for Disease Control group designated weak oxidizer group 1. CFA analysis, when supplemented by phenotypic characterization, is useful for the identification of L. mirabilis isolates.
- 1 November 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (11) , 4160-4162
Open AccessCellular Fatty Acid Composition of Lautropia mirabilis
Ten strains of Lautropia mirabilis (ATCC 51599 T and nine phenotypically similar clinical isolates) were examined for cellular fatty acid (CFA) composition to evaluate their chemical relatedness to known bacterial species and groups. The CFAs were liberated from whole cells by base hydrolysis, methylated, and analyzed by gas-liquid chromatography. CFA profiles were generated by using a commerical software package (MIDI, Newark, Del.). All strains tested had an identical CFA profile characterized by major amounts of 16:1ω7c (41%) and 16:0 (44%); smaller amounts (1 to 4%) of 3-OH-10:0, 12:0, 14:0, 15:0, and 18:1 ω7c; trace amounts (Acidovorax delafieldii, Comamonas terrigena , and strains of an unclassified Centers for Disease Control group designated weak oxidizer group 1. CFA analysis, when supplemented by phenotypic characterization, is useful for the identification of L. mirabilis isolates.
- 1 May 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (5) , 1819-1826
Assignment of CDC Weak Oxidizer Group 2 (WO-2) to the Genus Pandoraea and Characterization of Three New Pandoraea Genomospecies
CDC weak oxidizer group 2 (WO-2) consists of nine phenotypically similar human clinical isolates received by the Centers for Disease Control and Prevention between 1989 and 1998. Four of the isolates were from blood, three were from sputum, and one each was from bronchial fluid and maxillary sinus. All are aerobic nonfermentative, motile gram-negative rods with one to eight polar flagella per cell. All grew at 25 and 35°C and were positive for catalase, urease (usually delayed 3 to 7 days), citrate, alkalinization of litmus milk, oxidization of glycerol (weakly), and growth on MacConkey agar and in nutrient broth without NaCl. All except one strain were oxidase positive with the Kovács method, and all except one isolate weakly oxidized d -glucose. All were negative for oxidation of d -xylose, d -mannitol, lactose, sucrose, maltose, and 20 other carbohydrates, esculin hydrolysis, indole production, arginine dihydrolase, and lysine and ornithine decarboxylase. Only two of nine isolates reduced nitrate. Broth microdilution susceptibilities were determined for all strains against 13 antimicrobial agents. Most of the strains were resistant to ampicillin, extended-spectrum cephalosporins, and aminoglycosides, including gentamicin, tobramycin, and amikacin, but they varied in their susceptibility to fluoroquinolones. High-performance liquid chromatographic and mass spectrometric analyses of the WO-2 group identified ubiquinone-8 as the major quinone component. The percent G+C of the WO-2 strains ranged from 65.2 to 70.7% (thermal denaturation method). All shared a common cellular fatty acid (CFA) profile, which was characterized by relatively large amounts (7 to 22%) of 16:1ω7c, 16:0, 17:0cyc, 18:1ω7c, and 19:0cyc 11-12 ; small amounts (1 to 3%) of 12:0 and 14:0; and eight hydroxy acids, 2-OH-12:0 (4%), 2-OH-14:0 (trace), 3-OH-14:0 (12%), 2-OH-16:1 (1%), 2-OH-16:0 (3%), 3-OH-16:0 (4%), 2-OH-18:1 (2%), and 2-OH-19:0cyc (3%). This profile is similar to the CFA profile of Pandoraea , a recently described genus associated with respiratory infections in cystic fibrosis patients (T. Coenye et al., Int. J. Syst. Evol. Microbiol., 50:887–899, 2000). Sequencing of the 16S rRNA gene (1,300 bp) for all nine strains indicated a high level (≥98.8%) of homogeneity with Pandoraea spp. type strains. DNA-DNA hybridization analysis (hydroxyapatite method; 70°C) confirmed the identity of WO-2 with the genus Pandoraea and assigned three strains to Pandoraea apista and three to Pandoraea pnomenusa , and identified three additional new genomospecies containing one strain each (ATCC BAA-108, ATCC BAA-109, ATCC BAA-110). This study also shows that Pandoraea isolates may be encountered in blood cultures from patients without cystic fibrosis.
- 1 May 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (5) , 1819-1826
Assignment of CDC Weak Oxidizer Group 2 (WO-2) to the Genus Pandoraea and Characterization of Three New Pandoraea Genomospecies
CDC weak oxidizer group 2 (WO-2) consists of nine phenotypically similar human clinical isolates received by the Centers for Disease Control and Prevention between 1989 and 1998. Four of the isolates were from blood, three were from sputum, and one each was from bronchial fluid and maxillary sinus. All are aerobic nonfermentative, motile gram-negative rods with one to eight polar flagella per cell. All grew at 25 and 35°C and were positive for catalase, urease (usually delayed 3 to 7 days), citrate, alkalinization of litmus milk, oxidization of glycerol (weakly), and growth on MacConkey agar and in nutrient broth without NaCl. All except one strain were oxidase positive with the Kovács method, and all except one isolate weakly oxidized d -glucose. All were negative for oxidation of d -xylose, d -mannitol, lactose, sucrose, maltose, and 20 other carbohydrates, esculin hydrolysis, indole production, arginine dihydrolase, and lysine and ornithine decarboxylase. Only two of nine isolates reduced nitrate. Broth microdilution susceptibilities were determined for all strains against 13 antimicrobial agents. Most of the strains were resistant to ampicillin, extended-spectrum cephalosporins, and aminoglycosides, including gentamicin, tobramycin, and amikacin, but they varied in their susceptibility to fluoroquinolones. High-performance liquid chromatographic and mass spectrometric analyses of the WO-2 group identified ubiquinone-8 as the major quinone component. The percent G+C of the WO-2 strains ranged from 65.2 to 70.7% (thermal denaturation method). All shared a common cellular fatty acid (CFA) profile, which was characterized by relatively large amounts (7 to 22%) of 16:1ω7c, 16:0, 17:0cyc, 18:1ω7c, and 19:0cyc 11-12 ; small amounts (1 to 3%) of 12:0 and 14:0; and eight hydroxy acids, 2-OH-12:0 (4%), 2-OH-14:0 (trace), 3-OH-14:0 (12%), 2-OH-16:1 (1%), 2-OH-16:0 (3%), 3-OH-16:0 (4%), 2-OH-18:1 (2%), and 2-OH-19:0cyc (3%). This profile is similar to the CFA profile of Pandoraea , a recently described genus associated with respiratory infections in cystic fibrosis patients (T. Coenye et al., Int. J. Syst. Evol. Microbiol., 50:887–899, 2000). Sequencing of the 16S rRNA gene (1,300 bp) for all nine strains indicated a high level (≥98.8%) of homogeneity with Pandoraea spp. type strains. DNA-DNA hybridization analysis (hydroxyapatite method; 70°C) confirmed the identity of WO-2 with the genus Pandoraea and assigned three strains to Pandoraea apista and three to Pandoraea pnomenusa , and identified three additional new genomospecies containing one strain each (ATCC BAA-108, ATCC BAA-109, ATCC BAA-110). This study also shows that Pandoraea isolates may be encountered in blood cultures from patients without cystic fibrosis.